BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lang PO, Aspinall R. Vaccination for quality of life: herpes-zoster vaccines. Aging Clin Exp Res 2021;33:1113-22. [PMID: 31643072 DOI: 10.1007/s40520-019-01374-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ulaszewska M, Merelie S, Sebastian S, Lambe T. Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster. Hum Vaccin Immunother 2023;19:2175558. [PMID: 36785938 DOI: 10.1080/21645515.2023.2175558] [Reference Citation Analysis]
2 Giannelos N, Ng C, Curran D. Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review. Hum Vaccin Immunother 2023;:2168952. [PMID: 36916240 DOI: 10.1080/21645515.2023.2168952] [Reference Citation Analysis]
3 Wu S, Yang S, Ou M, Chen J, Huang J, Xiong D, Sun W, Xiao L. Transcriptome Analysis Reveals the Role of Cellular Calcium Disorder in Varicella Zoster Virus-Induced Post-Herpetic Neuralgia. Front Mol Neurosci 2021;14:665931. [PMID: 34079439 DOI: 10.3389/fnmol.2021.665931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hamad MA, Allam H, Sulaiman A, Murali K, Cheikh Hassan HI. Systematic Review and Meta-analysis of Herpes Zoster Vaccine in Patients With CKD. Kidney Int Rep 2021;6:1254-64. [PMID: 34013103 DOI: 10.1016/j.ekir.2021.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cantu C, Koch K, Cancino RS. Longitudinal, multidisciplinary, resident-driven intervention to increase immunisation rates for Medicaid, low-income and uninsured patients. BMJ Open Qual 2020;9:e000986. [DOI: 10.1136/bmjoq-2020-000986] [Reference Citation Analysis]